Newsfile

The newsfeed available here is provided by our content partner Newswire Corp.. It is a major and wide-reaching newswire & news provider that provides information, press releases and multimedia content for media, journalists and the general public. ActusNews enjoys a high reputation and great popularity, especially among listed companies in its home market North America.

The NewsWire Hub ("X-Billboard") currently comprises six of the most important international news sources and is supplemented by a stock market information service and additional RNS News. The individual newswire services complement each other and form a complementary information offering that covers more than three quarters of the official news sources on which editorial offices worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
F&G: 56
6.385,66 S&P · 17,30 Vola-Index · 116.482,01 BTC · 1,16553 EURUSD
System-State: Number of processed items 179.527 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              

Newsfile Corp. is an important, trusted and reliable news source for private investors, investors and traders, which can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. Those who want to take a closer look at the news can access the respective news item and other analysis tools directly via the detailed views of the info cards.

NEWS
EXPLORER
NL0011832936
State: 08.08.2025 | 5PM
Do you already know our new terminal view? Click here.
FIGI: BBG00CWWYK50
COPN

Cosmo Pharmaceuticals NV
GICS: 35202010 · Sector: EQTY · Sub-Sector: -
NAME
Cosmo Pharmaceuticals NV
ISIN
NL0011832936
TICKER
COPN
MIC
XSWX
REUTERS
COPN.S
BLOOMBERG
COPN SW
Fri, 08.08.2025       Cosmo Pharmaceuticals

Dublin, Ireland--(Newsfile Corp. - August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply agreement with Takeda (TSE: 4502) (NYSE: TAK), to produce Mesalazine MMX 1200 mg (marketed as Liald...
Wed, 23.07.2025       Cosmo Pharmaceuticals

Ad hoc announcement pursuant to Art. 53 LR EBITDA guidance raised by €4.5M as Cosmo executes on its Vision 2030 strategy; H1 Recurring Revenues from GI Genius™ up 128%, Winlevi® up 23%; Investors Call today at 2 pm CET. Dublin, Ireland--(Newsfile Corp. - July 23, 2025) - Cosmo Pharmaceuticals N...
Thu, 17.07.2025       Cosmo Pharmaceuticals

Dublin, Ireland--(Newsfile Corp. - July 17, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, is pleased to announce the launch of Winlevi® (clascoterone) cream 1% in Singapore and Malaysia, marking its first entry into Southeast Asia through the partnership with H...
Silent Ad
Wed, 16.07.2025       Cosmo Pharmaceuticals

Dublin, Ireland--(Newsfile Corp. - July 16, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced a major leap forward in its sustainability journey, underscoring its ambition to lead the next decade of healthcare innovation with purpose, transparency, and impact. ...
Tue, 01.07.2025       Cosmo Pharmaceuticals

Ad hoc announcement pursuant to Art. 53 LR Company sets ambitious vision for €480 million in recurring revenues and a 40% EBITDA margin by 2030; outlines roadmap for accelerated AI-driven growth and innovation.Dublin, Ireland--(Newsfile Corp. - July 1, 2025) - Cosmo N.V. (SIX: COPN), a global leader in AI-driven h...
Wed, 25.06.2025       Cosmo Pharmaceuticals

Dublin, Ireland--(Newsfile Corp. - June 25, 2025) - Cosmo today announced the signing of an agreement to sell “Digital Trust” to its existing customer Tinexta InfoCert, Europe’s largest Certification Authority and a subsidiary of Tinexta S.p.A., a publicly listed company in Italy. The transaction is expected to close by...
Tue, 24.06.2025       Cosmo Pharmaceuticals

Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that in July 2025, it will initiate their first usability study of a medical device software application connecting the Medtronic GI Genius™ intelligent endoscopy module, an AI-powered platform for gastrointestinal e...

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire crosslink panel in the upper area allows you to quickly and conveniently access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted research.


On behalf of the international investor community, we would like to thank Newswire Corp. for providing the news and data feeds

 

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S